Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Active not recruiting 9Completed 8Recruiting 7Terminated 6Unknown 5Withdrawn 1No longer available 1

Sponsor Class

OTHER 4NETWORK 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Sarcoma 5Gynecologic 3

Conditions

Breast Neoplasms 1871Neoplasms 1257Colorectal Neoplasms 1057Carcinoma, Non-Small-Cell Lung 1012Stomach Neoplasms 802Carcinoma, Hepatocellular 785Lung Neoplasms 769Prostatic Neoplasms 697Pancreatic Neoplasms 577Rectal Neoplasms 449Ovarian Neoplasms 406Colonic Neoplasms 405Neoplasm Metastasis 403Uterine Cervical Neoplasms 400Recurrence 382Leukemia, Myeloid, Acute 372Esophageal Neoplasms 363Multiple Myeloma 339Lymphoma 335Head and Neck Neoplasms 330Melanoma 312Precursor Cell Lymphoblastic Leukemia-Lymphoma 292Brain Neoplasms 264Urinary Bladder Neoplasms 256Liver Neoplasms 225Nasopharyngeal Carcinoma 223Leukemia 218Lymphoma, Large B-Cell, Diffuse 216Polycystic Ovary Syndrome 210Squamous Cell Carcinoma of Head and Neck 205

Interventions

Paclitaxel 2olaparib 1cediranib 1apatinib 1Taxes 1Nivolumab 1Ifosfamide 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Unknown × Carcinosarcoma × Clear all
NCT05537844 2022-09-23

BriTROC-2

Cancer Research UK, Glasgow

Unknown
250 enrolled
GynecologicSarcoma

Carcinosarcoma, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT05265793 2022-03-04

Camrelizumab Combined With Apatinib in the Treatment of Advanced Sarcomatoid Carcinoma or Carcinosarcoma

Fudan University

Phase 2 Unknown
45 enrolled
Sarcoma

Carcinoma, Carcinosarcoma

NCT03570437 2022-03-02

COPELIA

University of Manchester

Phase 2 Unknown
124 enrolled
GynecologicSarcoma

Carcinosarcoma, Neoplasms, Endometrial Neoplasms

NCT05224999 2022-02-04

Nivolumab for Recurrent/Metastatic Carcinosarcoma

Yonsei University

Phase 2 Unknown
28 enrolled
Sarcoma

Carcinosarcoma

NCT00954174 2021-09-30

Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer

GOG Foundation

Phase 3 Unknown
637 enrolled 18 charts
GynecologicSarcoma

Carcinosarcoma, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡